<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: prostate cancers</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Study finds gaps in 'decision aids' designed to help determine right cancer screening option</title>
   	 <description>When it comes to a cancer diagnosis, timing can be everything – the sooner it's found, the more treatable it is. But when and how often should someone get screened?</description>
     <link>http://medicalxpress.com/news/2013-05-gaps-decision-aids-cancer-screening.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 10 May 2013 12:23:14 EST</pubDate>
	 <guid isPermaLink="false">news287407277</guid>
	 
</item>
<item>
     <title>Hospital surgical volume should be considered when judging value of procedures</title>
   	 <description>The volume of cases performed at an institution each year has a direct effect on the outcome of surgical procedures, and should always be considered when looking at the benefits of a technique, according to a team of researchers at Henry Ford Hospital in Detroit.</description>
     <link>http://medicalxpress.com/news/2013-05-hospital-surgical-volume-procedures.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 05 May 2013 16:32:13 EST</pubDate>
	 <guid isPermaLink="false">news286990327</guid>
	 
</item>
<item>
     <title>New genetic link found between normal fetal growth and cancer</title>
   	 <description>Two researchers at the National Institutes of Health discovered a new genetic link between the rapid growth of healthy fetuses and the uncontrolled cell division in cancer. The findings shed light on normal development and on the genetic underpinnings of common cancers.</description>
     <link>http://medicalxpress.com/news/2013-04-genetic-link-fetal-growth-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 09 Apr 2013 04:20:29 EST</pubDate>
	 <guid isPermaLink="false">news284700022</guid>
	 
</item>
<item>
     <title>You can help reduce your colon cancer risk, expert says</title>
   	 <description>(HealthDay)—Colorectal cancer is the second leading cause of cancer death in the United States, but there are ways you can help prevent it, an expert says.</description>
     <link>http://medicalxpress.com/news/2013-03-colon-cancer-expert.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 08 Mar 2013 15:06:37 EST</pubDate>
	 <guid isPermaLink="false">news281977587</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/youcanhelpre.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find potential new therapeutic target for treating non-small cell lung cancer</title>
   	 <description>Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response.</description>
     <link>http://medicalxpress.com/news/2013-02-moffitt-potential-therapeutic-non-small-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Feb 2013 03:17:20 EST</pubDate>
	 <guid isPermaLink="false">news280120593</guid>
	 
</item>
<item>
     <title>Stress at work very unlikely to cause cancer, research says</title>
   	 <description>Work-related stress is not linked to the development of colorectal, lung, breast or prostate cancers, a study published today in BMJ suggests.</description>
     <link>http://medicalxpress.com/news/2013-02-stress-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 07 Feb 2013 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news279472501</guid>
	 
</item>
<item>
     <title>Sickle cells show potential to attack aggressive cancer tumors</title>
   	 <description>By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.</description>
     <link>http://medicalxpress.com/news/2013-01-sickle-cells-potential-aggressive-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 09 Jan 2013 17:00:06 EST</pubDate>
	 <guid isPermaLink="false">news276961342</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/76rbutff.jpg" width="90" height="90" />
</item>
<item>
     <title>HPV-associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage</title>
   	 <description>Despite the decline in cancer death rates in the U.S., there is an increase in incidence rates for cancers associated with human papillomavirus (HPV) infection and more efforts are needed to increase HPV vaccination coverage levels to prevent the occurrence of these cancers in the future according to a study published January 7 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2013-01-hpv-associated-cancer-incidence-efforts-hpv.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 07 Jan 2013 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news276772319</guid>
	 
</item>
<item>
     <title>US cancer screening rates decline over the last 10 years, study finds</title>
   	 <description>The rate of people who seek preventive cancer screenings has fallen over the last ten years in the United States with wide variations between white-collar and blue-collar workers, according to a University of Miami Miller School of Medicine study published on December 27 in the open-access journal Frontiers in Cancer Epidemiology.</description>
     <link>http://medicalxpress.com/news/2012-12-cancer-screening-decline-years.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 27 Dec 2012 02:00:01 EST</pubDate>
	 <guid isPermaLink="false">news275757596</guid>
	 
</item>
<item>
     <title>40 percent of cancer patients receive opioids at end of life</title>
   	 <description>(HealthDay)—For patients with one of five common cancers, 43.6 percent receive at least one prescription of opioids in the last three months of life, according to a study published in the Dec. 10 issue of the Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2012-12-percent-cancer-patients-opioids-life.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 13 Dec 2012 15:40:01 EST</pubDate>
	 <guid isPermaLink="false">news274633899</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/amp12640perc.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find new culprit in castration-resistant prostate cancer</title>
   	 <description>Scientists at Dana-Farber Cancer Institute have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones, which normally are needed to spur the cancer's growth. They say the finding could lead to a new treatment for prostate cancers that are no longer controlled by hormone-blocking drugs.</description>
     <link>http://medicalxpress.com/news/2012-12-culprit-castration-resistant-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Dec 2012 14:19:08 EST</pubDate>
	 <guid isPermaLink="false">news274630741</guid>
	 
</item>
<item>
     <title>Possible new treatment for Ewing sarcoma</title>
   	 <description>Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today's online issue of the journal Oncogene.</description>
     <link>http://medicalxpress.com/news/2012-11-treatment-ewing-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Nov 2012 13:49:26 EST</pubDate>
	 <guid isPermaLink="false">news273160157</guid>
	 
</item>
<item>
     <title>Cancer data in the 'cloud' could lead to more effective treatment</title>
   	 <description>Storing music and photos on distant computers via &quot;cloud&quot; technology is nothing new. But Johns Hopkins researchers are now using this tactic to collect detailed information from thousands of cancer cell samples. The goal is to help doctors make better predictions about how a patient's illness will progress and what type of treatment will be most effective.</description>
     <link>http://medicalxpress.com/news/2012-11-cancer-cloud-effective-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 06 Nov 2012 13:34:48 EST</pubDate>
	 <guid isPermaLink="false">news271431270</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cancerdatain.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists discover gene switch important in cancer</title>
   	 <description>Scientists at Karolinska Institutet in Sweden and the University of Helsinki in Finland have shown that the &quot;switches&quot; that regulate the expression of genes play a major role in the development of cancer. In a study, published in Science, they have investigated a gene region that contains a particular single nucleotide variant associated with increased risk for developing colorectal and prostate cancers – and found that removing this region caused dramatic resistance to tumor formation.</description>
     <link>http://medicalxpress.com/news/2012-11-scientists-gene-important-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 01 Nov 2012 14:00:37 EST</pubDate>
	 <guid isPermaLink="false">news270997228</guid>
	 
</item>
<item>
     <title>Nearly 170 million years of healthy life lost due to cancer in 2008</title>
   	 <description>The first detailed study to estimate the global impact of cancer on the number of healthy years of life lost by patients has revealed that nearly 170 million years of healthy life were lost because of cancer in 2008, according to an article published Online First in the Lancet.</description>
     <link>http://medicalxpress.com/news/2012-10-million-years-healthy-life-lost.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 15 Oct 2012 18:30:03 EST</pubDate>
	 <guid isPermaLink="false">news269520941</guid>
	 
</item>
<item>
     <title>3-D model for lung cancer mimics the real thing</title>
   	 <description>(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research over the last several decades.</description>
     <link>http://medicalxpress.com/news/2012-10-d-lung-cancer-mimics-real.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 11 Oct 2012 07:25:41 EST</pubDate>
	 <guid isPermaLink="false">news269159120</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3dmodelforlu.jpg" width="90" height="90" />
</item>
<item>
     <title>High toll of mental illness and addictions must be addressed</title>
   	 <description>Mental illnesses and addictions take more of a toll on the health of Ontarians than cancer or infectious diseases, according to a new report by the Institute for Clinical Evaluative Sciences and Public Health Ontario – yet this burden could be reduced with treatment, say scientists from Canada's Centre for Addiction and Mental Health (CAMH).</description>
     <link>http://medicalxpress.com/news/2012-10-high-toll-mental-illness-addictions.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Wed, 10 Oct 2012 13:12:53 EST</pubDate>
	 <guid isPermaLink="false">news269093563</guid>
	 
</item>
<item>
     <title>LPA1 inhibition induces metastatic dormancy in mouse models of breast cancer</title>
   	 <description>A lysophosphatidic acid receptor 1 (LPAR1) inhibitor, known as Debio-0719, suppresses the development of metastases in mice by inducing cancer cell dormancy, according to a study published August 21 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-08-lpa1-inhibition-metastatic-dormancy-mouse.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Aug 2012 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news264782231</guid>
	 
</item>
<item>
     <title>Human papilloma virus with Epstein Barr virus: Two-virus link to prostate cancer</title>
   	 <description>Two common viruses known to be associated with human cancers are both present &amp;#150; and may even be collaborating with each other - in most male prostate cancers, a new study suggests.</description>
     <link>http://medicalxpress.com/news/2012-07-human-papilloma-virus-epstein-barr.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 31 Jul 2012 14:47:37 EST</pubDate>
	 <guid isPermaLink="false">news262964836</guid>
	 
</item>
<item>
     <title>Limits to growth: Scientists identify key metastasis-enabling enzyme</title>
   	 <description>(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development of therapies based on identifying markers of metastasis associated with altered choline metabolism in breast, ovarian, and prostate cancers. Recently, scientists at the Leibniz Research Centre for Working Environment and Human Factors (IfADO), University of Dortmund, Germany, studying the tumor metabolome &amp;#8211; the characteristic metabolic phenotype of tumor cells fundamental to the tumor&amp;#8217;s metastatic capacity &amp;#8211; identified EDI3 (endometrial differential 3) as the enzyme responsible for a decreased glycerophosphocholine (GPC) to phosphocholine (PC) ratio by cleaving GPC to produce choline. The scientists concluded that since inhibiting EDI3 activity corrects the GPC/PC ratio and thereby decreases tumor cell migration capacity, it represents a possible therapeutic modality.</description>
     <link>http://medicalxpress.com/news/2012-05-limits-growth-scientists-key-metastasis-enabling.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 22 May 2012 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news256893186</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/hengstlerfigs5.jpg" width="90" height="90" />
</item>
<item>
     <title>Offering lung cancer screening as an insurance benefit would save lives at a relatively low cost</title>
   	 <description>Lung cancer is the most lethal cancer in the United States. According to the National Cancer Institute, lung cancer causes more than 150,000 deaths annually and has a survival rate of 16 percent. More Americans die of lung cancer each year than of cervical, breast, colon and prostate cancers combined.</description>
     <link>http://medicalxpress.com/news/2012-04-lung-cancer-screening-benefit.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 10 Apr 2012 09:34:55 EST</pubDate>
	 <guid isPermaLink="false">news253269286</guid>
	 
</item>
<item>
     <title>Prophylaxis with apixaban feasible for cancer patients</title>
   	 <description>(HealthDay) -- Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is safe and well tolerated, according to a phase II study published online March 12 in the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-03-prophylaxis-apixaban-feasible-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 29 Mar 2012 13:09:53 EST</pubDate>
	 <guid isPermaLink="false">news252245375</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/prophylaxisw.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers find important 'target' playing role in tobacco-related lung cancers</title>
   	 <description>Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance.</description>
     <link>http://medicalxpress.com/news/2012-02-important-role-tobacco-related-lung-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Feb 2012 12:55:37 EST</pubDate>
	 <guid isPermaLink="false">news248014519</guid>
	 
</item>
<item>
     <title>Britons to take part in Cuban lung cancer vaccine trial</title>
   	 <description> British patients will soon take part in a trial of a Cuban-designed therapeutic lung cancer vaccine, the first of its kind, a company executive announced Thursday.</description>
     <link>http://medicalxpress.com/news/2011-11-britons-cuban-lung-cancer-vaccine.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 25 Nov 2011 05:16:32 EST</pubDate>
	 <guid isPermaLink="false">news241420577</guid>
	 
</item>
<item>
     <title>Researchers find genetic rearrangements driving 5 to 7 percent of breast cancers</title>
   	 <description>Researchers at the University of Michigan Comprehensive Cancer Center have discovered two cancer-spurring gene rearrangements that may trigger 5 to 7 percent of all breast cancers.</description>
     <link>http://medicalxpress.com/news/2011-11-genetic-rearrangements-percent-breast-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 20 Nov 2011 13:28:00 EST</pubDate>
	 <guid isPermaLink="false">news241018065</guid>
	 
</item>
<item>
     <title>Breakthrough could make 'smart drugs' effective for many cancer patients</title>
   	 <description>(Medical Xpress) -- Newcastle and Harvard University reseachers have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors.</description>
     <link>http://medicalxpress.com/news/2011-06-breakthrough-smart-drugs-effective-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 27 Jun 2011 08:42:25 EST</pubDate>
	 <guid isPermaLink="false">news228382932</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/breakthrough.gif" width="90" height="90" />
</item>
<item>
     <title>Prostate cancer gets around hormone therapy by activating a survival cell signaling pathway</title>
   	 <description>Cancer is crafty. When one avenue driving its growth is blocked by drugs targeting that path, the malignancy often creates a detour, finding an alternative route to get around the roadblock.</description>
     <link>http://medicalxpress.com/news/2011-06-prostate-cancer-hormone-therapy-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 14 Jun 2011 15:06:34 EST</pubDate>
	 <guid isPermaLink="false">news227282778</guid>
	 
</item>
<item>
     <title>Half of prostate cancers could potentially benefit from new type of cancer drugs, study finds</title>
   	 <description>About half of prostate cancers have a genetic anomaly that appears to make tumor cells responsive to a new class of cancer-fighting drugs, a new study from the University of Michigan Comprehensive Cancer Center finds.</description>
     <link>http://medicalxpress.com/news/2011-05-prostate-cancers-potentially-benefit-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 May 2011 10:13:15 EST</pubDate>
	 <guid isPermaLink="false">news224932386</guid>
	 
</item>
<item>
     <title>New prostate cancer test more specific, sensitive than PSA test</title>
   	 <description>A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.</description>
     <link>http://medicalxpress.com/news/2011-05-prostate-cancer-specific-sensitive-psa.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 16 May 2011 17:25:51 EST</pubDate>
	 <guid isPermaLink="false">news224785527</guid>
	 
</item>


</channel>
</rss>
